Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

BACKGROUND: The natural history of prostate cancer is highly variable and difficult to predict accurately. Better markers are needed to guide management and avoid unnecessary treatment. In this study, we validate the prognostic value of a cell cycle progression score (CCP score) independently and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzick, J, Stone, S, Fisher, G, Yang, Z H, North, B V, Berney, D M, Beltran, L, Greenberg, D, Møller, H, Reid, J E, Gutin, A, Lanchbury, J S, Brawer, M, Scardino, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522632/
https://www.ncbi.nlm.nih.gov/pubmed/26103570
http://dx.doi.org/10.1038/bjc.2015.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522632/
https://www.ncbi.nlm.nih.gov/pubmed/26103570
http://dx.doi.org/10.1038/bjc.2015.223

Ejemplares similares